Safehouse, the nonprofit behind Philadelphia’s proposed supervised injection facility, is waiting on a federal judge to determine whether it’s legal to open the first medical site of its kind in the U ...
Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in New ...
Safehouse, the nonprofit behind Philadelphia’s proposed supervised injection facility, is waiting on a federal judge to determine whether it’s legal to open the first medical site of its kind in the U ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results